ArticleEnvironment & health (Washington, D.C.)2025
MPs Entering Human Circulation through Infusions: A Significant Pathway and Health Concern.
Article in Environment & health (Washington, D.C.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed.
- Review
- Gaps between Laboratory Experiments and Real-World Exposure: Toxicological Assessment of Microplastics Is Based on Inadequate Evidence.Environment & health (Washington, D.C.) · 2026Review
- Plasticizing Diabetes Care: The Metabolic Threat of Plastic-Associated Endocrine Disruptors and Micro-/Nanoplastics in Clinical Medicine.Current diabetes reports · 2026Review
- Long-Term Exposure to Fine Particulate Matter and Kidney Function among Patients with Polycystic Kidney Disease.Clinical journal of the American Society of Nephrology : CJASN · 2026Article
- Microplastics in Foods Intended for Health Purposes: From Dietary Supplements to Clinical Nutrition Products.Toxics · 2026Review
- Micro- and Nanoplastics as Emerging Drivers of Liver Injury: Exposure, Evidence, and Mechanisms.International journal of molecular sciences · 2026Review
- Dynamic Uptake and Elimination of Microplastics byEnvironment & health (Washington, D.C.) · 2026Article
- Effects of micro and nano plastics on renal health.World journal of nephrology · 2026Review
- Tracking Microplastics From Source to Impact: A Review of Environmental Presence, Exposure, Remediation, and Health Risks.Current environmental health reports · 2026Review
- Microplastics enhance the risk of cross-genus dissemination of carbapenemase resistance plasmids in ICU patients.Frontiers in cellular and infection microbiology · 2026Article
- Exposure to Nanoplastics and Co-Contaminants in Foods and Environment: Threats to Human Health.Foods (Basel, Switzerland) · 2025Review
- Separation and Detection of Microplastics in Human Exposure Pathways: Challenges, Analytical Techniques, and Emerging Solutions.Journal of xenobiotics · 2025Review
- Health Risks from Microplastics in Intravenous Infusions: Evidence from Italy, Spain, and Ecuador.Toxics · 2025Article
- From environment to brain: the role of microplastics in neurobehavioral disorders.Frontiers in neuroscience · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Human uptake of microplastic particles (MPs) is causing increasing health concerns, and there is mounting pressure to evaluate the associated risks. While MPs can be ingested, breathed in, or drank in, a very direct entrance channel is available through ingress into the bloodstream. Intravenous infusion usually proceeds from plastic bottles. Many are made of polypropylene (PP), and filtering is applied to limit particle contamination. In this study, we examined the MPs' content of filtrates using a combination of surface-enhanced Raman spectroscopy and scanning electron microscopy. We find that the number of PP particles is significant (∼7500 particles/L). The MP sizes range from 1 to 62 μm, with a median of ∼8.5 μm. About 90% of particles ranged between 1 and 20 μm in size, with ∼60% in the range 1 to 10 μm. We then discuss the potential number of such particles injected and the consequences of their presence in the bloodstream. We highlight the organs for potential deposition, and we discuss possible clinical effects. Our quantitative data are important to help evaluate the toxicity risks associated with MPs and to accurately balance those risks versus the benefits of using intravenous injections.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.